Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 700 shares at $151.22 ($106K) on 2018-03-15, disclosed to the SEC on 2018-03-19.
Seasonal sale ($106k) by EVP & CFO — this insider has traded JAZZ in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |